Biogen
(NASDAQ:BIIB)
$235.32
8.44[3.72%]
At close: May 15
$235.32
0[0.00%]
After Hours: 5:55PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open$228.980
Close$235.320
Volume / Avg.1.793M / 1.270M
Day Range228.660 - 236.900
52 Wk Range189.440 - 334.580
Market Cap$34.262B
P/E Ratio28.360
Dividend Yield-
ExchangeNASDAQ
RSI
74
Short Interest
2.53%
Days to Cover3.33

Recent News

Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank
Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a favorite."
Avi Kapoor
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Shanthi Rexaline
These Analysts Revise Their Forecasts On Biogen After Q1 Results
Avi Kapoor
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
11
2
Feb
2
Mar
5
7
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BIIB
LEGN

FAQ

Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biogen's (BIIB) competitors?

A

Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Friday, May 3, 2024. The analyst firm set a price target for 342.00 expecting BIIB to rise to within 12 months (a possible 45.33% upside). 80 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $235.32 last updated May 15, 2024 at 5:55 PM EDT.

Q

Does Biogen (BIIB) pay a dividend?

A

There are no upcoming dividends for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q2 earnings are confirmed for Tuesday, July 23, 2024.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch